Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
548 INR | -0.49% | +2.40% | +65.86% |
04-18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
04-17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.86% | 573M | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- Market Chatter: Shilpa Medicare's Drug for Psoriatic Arthritis Gets Tentative Nod by US Drug Regulator